Thrivent Financial for Lutherans
Position in ELAN — Elanco Animal Health Inc
CIK 314984
Minneapolis, MN
Position in ELAN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$18,380,101
+$11,720,670 QoQ
Shares Held
746,855
+168.4% QoQ
Ownership
0.149%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#69
of 515 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Thrivent Financial for Lutherans holds $170,891,735 across 22 Drug Manufacturers - Specialty & Generic names. ELAN ranks #3 (10.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
128,626 | $69,693,424 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
297,297 | $50,106,435 | |
| 3 | ELAN |
Elanco Animal Health Inc
This page
|
746,855 | $18,380,101 | |
| 4 | ALKS |
Alkermes plc.
|
109,450 | $5,735,180 | |
| 5 | LQDA |
Liquidia Corp
|
46,133 | $3,678,184 | |
| 6 | VTRS |
Viatris Inc
|
230,572 | $3,661,482 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
80,062 | $3,284,943 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
113,125 | $1,958,193 |
All Filings in ELAN
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,380,101 | 746,855 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,659,431 | 278,288 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $4,855,560 | 214,563 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $4,723,957 | 234,556 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $3,356,613 | 235,057 | Shares | Defined | 2025-08-26 | |
| 2025-03-31 | $2,468,098 | 235,057 | Shares | Defined | 2025-08-26 | |
| 2024-12-31 | $2,846,539 | 235,057 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $8,008,473 | 545,165 | Shares | Defined | 2024-11-07 | |
| 2024-06-30 | $7,881,536 | 546,191 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $10,672,287 | 655,546 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $15,796,487 | 1,060,167 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $12,591,441 | 1,120,235 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $7,023,046 | 698,116 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,086,818 | 115,619 | Shares | Defined | 2023-05-17 | |
| 2022-12-31 | $928,242 | 75,961 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $942,675 | 75,961 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,491,113 | 75,961 | Shares | Defined | 2022-08-16 | |
| 2022-03-31 | $1,968,933 | 75,467 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,353,271 | 47,684 | Shares | Defined | 2022-02-16 | |
| No filing history on record for this holder in this stock. | ||||||